Officially lowering the evidentiary bar creates a predictable risk: more companies may highlight their most favorable study while downplaying or withholding less supportive results -- data the public ...
SAN ANTONIO -- Many patients with early breast cancer can safely skip sentinel lymph node biopsy (SLNB), results of a large Dutch study suggested.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback